Rheumatoid arthritis and lung cancer: You probably heard it before

Journal of Rheumatology

Volumn 35, Issue 9, 2008, Pages 1695-1696

  Kallberg, Henrik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CANCER DIAGNOSIS; CANCER RISK; CHROMOSOME 15; DISEASE ASSOCIATION; EDITORIAL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HUMAN; LUNG CANCER; MEDICAL INFORMATION; MEDICAL LITERATURE; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING;

ARTHRITIS, RHEUMATOID; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; RISK FACTORS; SMOKING;

EID: 54049119301     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. BMJ 1950;ii:739-48.
2. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-40. Epub 2008 Mar 10.
3. Linn-Rasker SP, van der Helm-van Mil AH, Van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006;65:366-71.
4. Pedersen M, Jacobsen S, Garred P, et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007;56:1446-53.
5. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of RA: Smoking may trigger HLA-DR (SE)- restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
6. Khurana R, Wolf R, Berney S, Caldito G, Hayat S, Berney SM. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: A large case control study in US veterans. J Rheumatol 2008;35:1704-8.
7. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95.
8. Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:R45 [Epub ahead of print].
9. Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology Oxford 2008;47:698-701.
10. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
11. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
12. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.
13. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007;357:1199-209.
14. Askling J. Malignancy and rheumatoid arthritis. Curr Rheumatol Rep 2007;9:421-6.